Sudheer Paruchuri, MD Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 1515 N Harlem Ave Ste 100, Oak Park, IL 60302 Phone: 312-473-4748 Fax: 312-924-5924 |
Dr. Alexander Chi, Radiology - Radiation Oncology Medicare: Medicare Enrolled Practice Location: 100 Forest Pl, Apt 402, Oak Park, IL 60301 Phone: 773-494-4412 |
Mark Weldon Arnett, M.D. Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 3 Erie Ct, Oak Park, IL 60302 Phone: 707-783-3532 Fax: 708-782-3164 |
Dr. Vikram Krishan Sobti, M.D. Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 949 Fair Oaks Ave, Oak Park, IL 60302 Phone: 952-595-1100 Fax: 612-294-4903 |
Julio V Rossi, MD Radiology - Diagnostic Radiology Medicare: Medicare Enrolled Practice Location: 3 Erie Court, West Suburban Hospital, Oak Park, IL 60302 Phone: 708-386-6565 Fax: 708-386-6589 |
News Archive
Prevently.com is a new health and wellness portal that aims to help people live a healthier lifestyle. The website provides users with health information reviewed by physicians, virtual video coaching with dietitians, a personal health record that integrates with wearable fitness devices such as FitBit, social networking tools, and an ecommerce portal that allows users to purchase health products and food reviewed by physicians.
A new study shows the correlation between serum levels of antibodies to SARS-CoV-2 and levels in breast milk following the vaccination of lactating women with a vaccine based on mRNA technology.
A piece of research submitted by the Artificial Intelligence and Approximate Reasoning Group (GIARA) of the NUP/UPNA-Public University of Navarre received an award from the European Association of Fuzzy Logic and Soft Computing (EUSFLAT) during its biennial meeting (EUSFLAT 2013) held in Milan last week.
New results of an NDSU study indicate devastating floods can have an effect on the next generation. The big question is, "why?"
Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc., today announced that they have initiated a Phase I clinical trial of AGS-16M8F an antibody-drug conjugate (ADC) that is being developed for the treatment of metastatic renal cancer. An ADC uses the specific binding properties of an antibody to target a toxin in tumor cells, resulting in selective tumor cell killing.
› Verified 5 days ago